Econtra One-step Tablet
Product Images NDC 50102-211

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Econtra One-step (NDC 50102-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1.5 mg (6 Blister Carton Label))

This is a description of a drug called EContra One-Step, containing levonorgestrel, an emergency contraceptive. The drug reduces the chance of pregnancy after unprotected sex and is not for regular birth control. The drug comes in one tablet of 1.5mg. The package includes three mono cartons of one tablet each, manufactured for Afaxys Pharma. The drug is not harmful to an existing pregnancy. Aurobindo Pharma Limited is the manufacturer of the drug located in Mahabubnagar, India. The drug packaging contains all the necessary information on usage, warnings, and emergency contact numbers.*

FDA Label Image

Package Label-principal Display Panel (1.5 mg (6 Blister Carton Label))

EContra One-Step is an emergency contraceptive with the active ingredient Levonorgestrel. It is used to reduce the chances of pregnancy after unprotected sex and is not meant for regular birth control. The tablet must be taken within 72 hours (3 days) of unprotected sex to be the most effective. It will not harm an existing pregnancy. EContra One-Step is manufactured by Aurobindo Pharma in India and is made available by Afaxys Pharma LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.